Benight NM - Search Results

1

Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.

Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Bourn JR, et al. Among authors: benight nm. Cancer Lett. 2021 Apr 10;503:75-90. doi: 10.1016/j.canlet.2021.01.019. Epub 2021 Jan 27. Cancer Lett. 2021. PMID: 33508385 Free PMC article.

2

Ron receptor tyrosine kinase signaling as a therapeutic target.

Benight NM, Waltz SE. Benight NM, et al. Expert Opin Ther Targets. 2012 Sep;16(9):921-31. doi: 10.1517/14728222.2012.710200. Epub 2012 Jul 26. Expert Opin Ther Targets. 2012. PMID: 22834780 Free PMC article. Review.

3

HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.

Benight NM, Wagh PK, Zinser GM, Peace BE, Stuart WD, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. Benight NM, et al. Oncotarget. 2015 Jul 10;6(19):17445-61. doi: 10.18632/oncotarget.3641. Oncotarget. 2015. PMID: 25938541 Free PMC article.

4

HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.

Ruiz-Torres SJ, Benight NM, Karns RA, Lower EE, Guan JL, Waltz SE. Ruiz-Torres SJ, et al. Among authors: benight nm. Oncotarget. 2017 Jul 22;8(35):58918-58933. doi: 10.18632/oncotarget.19441. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938607 Free PMC article.

5

Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35.

Ruiz-Torres SJ, Bourn JR, Benight NM, Hunt BG, Lester C, Waltz SE. Ruiz-Torres SJ, et al. Among authors: benight nm. Oncogene. 2022 Jan;41(3):321-333. doi: 10.1038/s41388-021-02091-y. Epub 2021 Nov 6. Oncogene. 2022. PMID: 34743208 Free PMC article.

6

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.

Privette Vinnedge LM, Benight NM, Wagh PK, Pease NA, Nashu MA, Serrano-Lopez J, Adams AK, Cancelas JA, Waltz SE, Wells SI. Privette Vinnedge LM, et al. Among authors: benight nm. Oncogene. 2015 Apr 30;34(18):2325-36. doi: 10.1038/onc.2014.173. Epub 2014 Jun 23. Oncogene. 2015. PMID: 24954505 Free PMC article.

7

RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk.

Hunt BG, Jones A, Lester C, Davis JC, Benight NM, Waltz SE. Hunt BG, et al. Among authors: benight nm. Cancers (Basel). 2022 May 19;14(10):2493. doi: 10.3390/cancers14102493. Cancers (Basel). 2022. PMID: 35626096 Free PMC article.

8

Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.

Han X, Osuntokun B, Benight N, Loesch K, Frank SJ, Denson LA. Han X, et al. Am J Pathol. 2006 Dec;169(6):1999-2013. doi: 10.2353/ajpath.2006.060186. Am J Pathol. 2006. PMID: 17148664 Free PMC article.

9

Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis.

Han X, Benight N, Osuntokun B, Loesch K, Frank SJ, Denson LA. Han X, et al. Gut. 2007 Jan;56(1):73-81. doi: 10.1136/gut.2006.094490. Epub 2006 Jun 15. Gut. 2007. PMID: 16777921 Free PMC article.

10

B-vitamin deficiency is protective against DSS-induced colitis in mice.

Benight NM, Stoll B, Chacko S, da Silva VR, Marini JC, Gregory JF 3rd, Stabler SP, Burrin DG. Benight NM, et al. Am J Physiol Gastrointest Liver Physiol. 2011 Aug;301(2):G249-59. doi: 10.1152/ajpgi.00076.2011. Epub 2011 May 19. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21596995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters